Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K K Winer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JAMA|August 28, 1996
Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidismK K Winer, J A Yanovski, G B Cutler
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidismK K Winer, J A Yanovski, B Sarani, et al.
Pediatric Research|October 6, 1997
A Ca(2+)-sensing receptor mutation causes hypoparathyroidism by increasing receptor sensitivity to Ca2+ and maximal signal transductionE E Mancilla, F De Luca, K Ray, et al.
Human Molecular Genetics|May 1, 1996
Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidismJ Baron, K K Winer, J A Yanovski, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Sporadic hypoparathyroidism caused by de Novo gain-of-function mutations of the Ca(2+)-sensing receptorF De Luca, K Ray, E E Mancilla, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 15, 2014
Anthropometric models of bone mineral content and areal bone mineral density based on the bone mineral density in childhood studyD F Short, V Gilsanz, H J Kalkwarf, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 25, 2010
Fitting of bone mineral density with consideration of anthropometric parametersD F Short, B S Zemel, V Gilsanz, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JAMA|August 28, 1996
Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidismK K Winer, J A Yanovski, G B Cutler
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidismK K Winer, J A Yanovski, B Sarani, et al.
Pediatric Research|October 6, 1997
A Ca(2+)-sensing receptor mutation causes hypoparathyroidism by increasing receptor sensitivity to Ca2+ and maximal signal transductionE E Mancilla, F De Luca, K Ray, et al.
Human Molecular Genetics|May 1, 1996
Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidismJ Baron, K K Winer, J A Yanovski, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Sporadic hypoparathyroidism caused by de Novo gain-of-function mutations of the Ca(2+)-sensing receptorF De Luca, K Ray, E E Mancilla, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 15, 2014
Anthropometric models of bone mineral content and areal bone mineral density based on the bone mineral density in childhood studyD F Short, V Gilsanz, H J Kalkwarf, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 25, 2010
Fitting of bone mineral density with consideration of anthropometric parametersD F Short, B S Zemel, V Gilsanz, et al.
Pageof 1